Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma
Clinical trial NCT01092728 · TERMINATED
Trial details
- NCT number
- NCT01092728
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-08-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.